1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : BIOTECHNOLOGY
  4. BIOCON LTD.
392.65 4.30 (1.11%)
4.3M
NSE+BSE Volume

NSE 05 Dec, 2025 3:55 PM (IST)

Watchlist

Portfolio

Alert

Analyst Buy
Axis Direct maintains its 'Buy' rating on Biocon, expects a revenue CAGR of 19.8% over FY26-27 See details